Clinical Trials on Advanced Solid Tumors in United Kingdom
Total 11251 results
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
BeiGeneCompletedAdvanced Solid TumorsUnited Kingdom
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
Cancer Research UKCompleted
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
Eisai Inc.Completed
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Cancer Research UKTerminatedAdvanced Solid TumoursUnited Kingdom
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
UCB Biopharma SRLActive, not recruitingAdvanced Solid TumorsUnited States, United Kingdom
-
AstraZenecaSyneos HealthCompletedAdvanced Solid TumoursUnited States, Spain, Korea, Republic of, United Kingdom
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States, United Kingdom, Italy
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
ADC Therapeutics S.A.Active, not recruitingAdvanced Solid TumorsUnited States, Spain, United Kingdom
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, Canada, United Kingdom
-
Exscientia AI LimitedGT Apeiron LLCRecruitingAdvanced Solid TumorUnited Kingdom, Belgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, United Kingdom, Spain
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
PfizerCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom
-
T3 Pharmaceuticals AGRecruiting
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
Nuvectis Pharma, Inc.RecruitingAdvanced Solid TumorUnited States, United Kingdom
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Affimed GmbHActive, not recruitingAdvanced Solid TumorUnited States, Korea, Republic of, Spain, Germany, United Kingdom
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Advanced Hematologic TumorsUnited States, Australia
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
NeuPharma, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States
-
BicycleTx LimitedRecruitingAdvanced Solid TumorUnited States, United Kingdom